Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on: April 18,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on:April 18,2024

Cell division, DNA repair and cancer progression closely tied to CDK9 dysfunction

by Sbarro Health Research Organization (SHRO)CDK9 isoforms regulate DNA damage response.AWestern blot analysis of CDK9 in HeLa cells transfected with siRNA CDK9 (siCDK9) or control (siCTR)

Updated on: March 20,2024

Cell division, DNA repair and cancer progression closely tied to CDK9 dysfunction

by Sbarro Health Research Organization (SHRO)CDK9 isoforms regulate DNA damage response.AWestern blot analysis of CDK9 in HeLa cells transfected with siRNA CDK9 (siCDK9) or control (siCTR)

Updated on:March 20,2024

Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumorA type of glioma. Credit: David Ellison, St. Jude Children’s Research HospitalRibociclib—a drug already used to treat breast cancer—may help s

Updated on: September 10,2024

Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumorA type of glioma. Credit: David Ellison, St. Jude Children’s Research HospitalRibociclib—a drug already used to treat breast cancer—may help s

Updated on:September 10,2024

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on: March 06,2024

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on:March 06,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on: February 24,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on:February 24,2024

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on: January 22,2024

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on:January 22,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on: July 05,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on:July 05,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on: February 03,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on:February 03,2024

'Cancer-blocking' protein offers potential to transform cells from destructive to constructive

byAustralian National UniversityNLRC4 attenuates tumor development inApcmin/+mice. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01988-6An immune protein could

Updated on: November 10,2024

'Cancer-blocking' protein offers potential to transform cells from destructive to constructive

byAustralian National UniversityNLRC4 attenuates tumor development inApcmin/+mice. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01988-6An immune protein could

Updated on:November 10,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on: April 09,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on:April 09,2024

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on: January 11,2024

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on:January 11,2024